P

Inventor

HYNES JOHN

IE62 patents
⚠️ This page may combine multiple inventors who share the name “HYNES JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

32 patents
US6670357B2Dec 30, 2003

Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO137 citations95
US6653304B2Nov 25, 2003

Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases

BRISTOL MYERS SQUIBB CO62 citations93
US7160883B2Jan 9, 2007

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO23 citations92
US7601844B2Oct 13, 2009

Piperidinyl derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO19 citations91
US10294229B2May 21, 2019

Heteroaryl substituted aminopyridine compounds

BRISTOL MYERS SQUIBB CO9 citations84
US7323482B2Jan 29, 2008

Thiazolyl-based compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO12 citations84
US7169771B2Jan 30, 2007

Thiazolyl-based compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations84
US9862715B2Jan 9, 2018

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO5 citations83
US8987311B2Mar 24, 2015

Triazolyl-substituted pyridyl compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO14 citations83
US7759343B2Jul 20, 2010

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO11 citations83
US7034151B2Apr 25, 2006

Process for preparing pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO17 citations82
US12286428B2Apr 29, 2025

Tricyclic heteroaryl compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO2 citations74
US7314876B2Jan 1, 2008

Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO7 citations74
US9242975B2Jan 26, 2016

Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO4 citations72
US10202390B2Feb 12, 2019

Heteroaryl substituted aminopyridine compounds

BRISTOL MYERS SQUIBB CO3 citations71
US9657009B2May 23, 2017

Heteroaryl substituted pyridyl compounds useful as kinase modulators

BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017

Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators

BRISTOL MYERS SQUIBB CO5 citations71
US9169252B2Oct 27, 2015

Heteroaryl substituted nicotinamide compounds

BRISTOL MYERS SQUIBB CO5 citations71
US7935696B2May 3, 2011

Heterocyclic amide compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations63
US7642257B2Jan 5, 2010

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations63
US7419978B2Sep 2, 2008

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO2 citations63
US9242976B2Jan 26, 2016

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US7985861B2Jul 26, 2011

Piperidinyl derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO3 citations61
US12304914B2May 20, 2025

Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US12304916B2May 20, 2025

Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US10544133B2Jan 28, 2020

Heteroaryl substituted pyridyl compounds useful as kinase modulators

BRISTOL MYERS SQUIBB CO0 citations52
US9221819B2Dec 29, 2015

Spirocyclic compounds as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US12492186B2Dec 9, 2025

Bicyclic heterocyclic compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US10227340B2Mar 12, 2019

Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US10023562B2Jul 17, 2018

Heteroaryl substituted pyridyl compounds useful as kinase modulators

BRISTOL MYERS SQUIBB CO0 citations51
US12570659B2Mar 10, 2026

Bicyclic heteroaryl compounds useful as IRAK4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations50

VIAVI SOLUTIONS INC

6 patents

JDS UNIPHASE CORP

3 patents

KEYMED MEDICAL & IND EQUIPMENT LTD

3 patents

(unassigned)

1 patent

SAMTEC INC

1 patent

RAIN BASKETBALL INC

1 patent

HYNES JOHN

1 patent

GARDNER DANIEL S

1 patent

HARMONY MEDICAL LTD

1 patent

Showing the top 50 of 62 patents by PatentIndex Score.